BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36179239)

  • 1. Rituximab for Acquired Hemophilia A in the Setting of Bullous Pemphigoid.
    Bell MC; Grove DC; Isaacs MJ; Mark LA
    Cutis; 2022 Jul; 110(1):E23-E24. PubMed ID: 36179239
    [No Abstract]   [Full Text] [Related]  

  • 2. Acquired hemophilia A in a Taiwanese patient with bullous pemphigoid.
    Wang YH; Wu WC; Hsiao LT; Ma SH; Chen CC; Ho YH
    Int J Rheum Dis; 2023 Sep; 26(9):1838-1839. PubMed ID: 37182928
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of acquired hemophilia associated with bullous pemphigoid.
    Gupta S; Mahipal A
    Am J Hematol; 2007 Jun; 82(6):502. PubMed ID: 17301969
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of acquired haemophilia A in a patient with bullous pemphigoid and review of the Japanese literature.
    Chijiwa C; Kamata M; Fukuyasu A; Shono Y; Takeoka S; Tateishi M; Fukaya S; Hayashi K; Tanaka T; Ishikawa T; Ohnishi T; Saito K; Ishii N; Hashimoto T; Tada Y
    Eur J Dermatol; 2018 Jun; 28(3):422-423. PubMed ID: 29952290
    [No Abstract]   [Full Text] [Related]  

  • 5. Favourable progression of acquired hemophilia-associated bullous pemphigoid.
    Caudron A; Chatelain D; Christophe O; Lok C; Roussel B; Viseux V
    Eur J Dermatol; 2009; 19(4):383-4. PubMed ID: 19451049
    [No Abstract]   [Full Text] [Related]  

  • 6. Acquired Haemophilia A in DPP4 Inhibitor-induced Bullous Pemphigoid as Immune Reconstitution Syndrome.
    Sugiyama S; Tanaka R; Hayashi H; Izumi K; Nishie W; Aoyama Y
    Acta Derm Venereol; 2020 Jun; 100(13):adv00178. PubMed ID: 32494825
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bullous pemphigoid and acquired haemophilia].
    Kluger N; Navarro R; Pallure V; Guillot B
    Ann Dermatol Venereol; 2011 May; 138(5):422-3. PubMed ID: 21570569
    [No Abstract]   [Full Text] [Related]  

  • 8. Bullous pemphigoid: Rituximab to the rescue?
    Heymann WR
    J Am Acad Dermatol; 2020 May; 82(5):1089-1090. PubMed ID: 32119892
    [No Abstract]   [Full Text] [Related]  

  • 9. Rituximab Treatment of Nivolumab-Induced Bullous Pemphigoid.
    Sowerby L; Dewan AK; Granter S; Gandhi L; LeBoeuf NR
    JAMA Dermatol; 2017 Jun; 153(6):603-605. PubMed ID: 28355425
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pemphigoid and acquired hemophilia].
    Lightburn E; Morand JJ; Graffin B; Molinier S; Raphenon G; Poullin P; Harlé JR; Chouc C
    Ann Dermatol Venereol; 2001 Nov; 128(11):1229-31. PubMed ID: 11908168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired hemophilia associated with bullous pemphigoid: a case report.
    Qiu X; Zhang G; Xiao R; Zhang J; Zhou Y; Li G; Yan K; Lu Q
    Int J Clin Exp Pathol; 2012; 5(1):102-4. PubMed ID: 22295154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bullous Pemphigoid Successfully Treated with Rituximab].
    Silva N; Costa A; Salvador F; Serradeiro E
    Acta Med Port; 2017 Mar; 30(3):243-246. PubMed ID: 28550834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acquired hemophilia A associated with bullous pemphigoid and multiple myeloma: a case report].
    Sourdeau É; Clauser S; Prud'Homme R; Bardet V; Calmette L
    Ann Biol Clin (Paris); 2019 Apr; 77(2):179-183. PubMed ID: 30882350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onset of acquired haemophilia A after omalizumab treatment in severe bullous pemphigoid - a report on two cases successfully treated with mycophenolate mofetil.
    Mangin MA; Lienhart A; Gouraud A; Roux S; Hodique F; Jouen F; Balme B; Dalle S; Debarbieux S
    Ann Dermatol Venereol; 2021 Mar; 148(1):57-59. PubMed ID: 33461795
    [No Abstract]   [Full Text] [Related]  

  • 15. Rituximab therapy in patients with bullous pemphigoid: A retrospective study of 20 patients.
    Polansky M; Eisenstadt R; DeGrazia T; Zhao X; Liu Y; Feldman R
    J Am Acad Dermatol; 2019 Jul; 81(1):179-186. PubMed ID: 30923002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab and Omalizumab Combination Therapy for Bullous Pemphigoid.
    Le ST; Herbert S; Haughton R; Nava J; Toussi A; Ji-Xu A; Maverakis E
    JAMA Dermatol; 2024 Jan; 160(1):107-109. PubMed ID: 37991748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three cases of refractory bullous pemphigoid in the elderly treated successfully with ultra-low-dose rituximab.
    Chen Q; Hu B; Wan L; Hu L; Zhou X; Chen L; Chen J
    J Dermatol; 2023 Apr; 50(4):561-564. PubMed ID: 36539929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bullous pemphigoid associated with acquired hemophilia a: a rare association of autoimmune disease.
    Aljasser MI; Sladden C; Crawford RI; Au S
    J Cutan Med Surg; 2014; 18(2):123-6. PubMed ID: 24636438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical response to rituximab and improvement in quality of life in patients with bullous pemphigoid and mucous membrane pemphigoid.
    Rashid H; Meijer JM; Bolling MC; Horváth B
    Br J Dermatol; 2022 Apr; 186(4):721-723. PubMed ID: 34747507
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bullous pemphigoid and acquired hemophilia].
    Soria A; Matichard E; Descamps V; Crickx B
    Ann Dermatol Venereol; 2007 Apr; 134(4 Pt 1):353-6. PubMed ID: 17483755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.